title: Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: need for heightened awareness.
authors.forename: H J
authors.initials: HJ
authors.lastname: Eaton
authors.forename: P J
authors.initials: PJ
authors.lastname: Phillips
authors.forename: A
authors.initials: A
authors.lastname: Hanieh
authors.forename: J
authors.initials: J
authors.lastname: Cooper
authors.forename: J
authors.initials: J
authors.lastname: Bolt
authors.forename: D J
authors.initials: DJ
authors.lastname: Torpy
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D017273:Goserelin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010899:Pituitary Apoplexy / Q000139:chemically induced*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin